国产在线拍偷自揄拍无码,欧美成人精品高清在线观看,又粗又黄又爽视频免费看,亚洲精品一区二区久久

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

四虎影视www在线观看免费| 99久久99久久精品国产片| 久热这里只有精品视频6| 曰本真人做爰无遮挡| 9制片厂制片传媒在线播放| 久久久久久亚洲av无码专区| 无码精品一区二区三区在线| gogo西西人体做爰大胆视频图| 欧美极品少妇×XXXBBB| 国产精品99久久久久久www| 无码丰满少妇2在线观看| 性xxxx欧美老妇胖老太肥肥| 亚洲heyzo专区无码综合| 久久黄色视频| 亚洲国产一区二区三区| 50歳のバツ1熟女とハメ撮り| 77777亚洲午夜久久多喷| 啊轻点灬太粗太长了a片| 欧产日产国产精品| 亚洲成a人片77777kkkk| 东北女人毛多水多牲交视频| 99热这里有精品| 色综合久久无码五十路人妻 | 欧美丰满熟妇xxxx性大屁股| 地铁上两个人一前一后攻击| 深田咏美av一区二区三区| 年轻的小婊2韩剧中文版| 被主人在调教室sm惩罚 | 12—13女人做a片| 人妻影音先锋啪啪av资源| 国产精品户外野外| 久久亚洲私人国产精品va| 欧美 变态 另类 人妖| 一个人在线观看视频的免费| 精品久久久久久中文字幕大豆网| 日韩色欲人妻无码精品av| 男女做爰裸体猛烈吃奶摸视频| 日本japanese丰满白浆| 亚洲精品卡一卡2卡3卡4卡| 女女互揉吃奶揉到高潮视频| 宅宅少妇无码|